Integra LifeSciences Holdings Corporation (IART)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.17B |
| Enterprise value | 4.46B |
| Trailing P/E | 24.63 |
| Forward P/E | 10.96 |
| PEG ratio (5-yr expected) | 0.91 |
| Price/sales (ttm) | 2.08 |
| Price/book (mrq) | 1.88 |
| Enterprise value/revenue | 2.89 |
| Enterprise value/EBITDA | 13.61 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.20 |
| 52-week change 3 | -10.30% |
| S&P500 52-week change 3 | 17.14% |
| 52-week high 3 | 60.69 |
| 52-week low 3 | 37.36 |
| 50-day moving average 3 | 42.77 |
| 200-day moving average 3 | 49.91 |
Share statistics
| Avg vol (3-month) 3 | 646.42k |
| Avg vol (10-day) 3 | 752.01k |
| Shares outstanding 5 | 81.4M |
| Implied shares outstanding 6 | 81.4M |
| Float 8 | 70.26M |
| % held by insiders 1 | 13.15% |
| % held by institutions 1 | 92.34% |
| Shares short (30 Aug 2023) 4 | 2.57M |
| Short ratio (30 Aug 2023) 4 | 4.94 |
| Short % of float (30 Aug 2023) 4 | 3.63% |
| Short % of shares outstanding (30 Aug 2023) 4 | 3.15% |
| Shares short (prior month 30 July 2023) 4 | 2.4M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 03 Jan 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 June 2023 |
Profitability
| Profit margin | 8.50% |
| Operating margin (ttm) | 16.44% |
Management effectiveness
| Return on assets (ttm) | 4.22% |
| Return on equity (ttm) | 7.85% |
Income statement
| Revenue (ttm) | 1.55B |
| Revenue per share (ttm) | 18.84 |
| Quarterly revenue growth (yoy) | -4.20% |
| Gross profit (ttm) | 982.03M |
| EBITDA | 374.99M |
| Net income avi to common (ttm) | 131.27M |
| Diluted EPS (ttm) | 1.56 |
| Quarterly earnings growth (yoy) | -90.70% |
Balance sheet
| Total cash (mrq) | 329.39M |
| Total cash per share (mrq) | 4.05 |
| Total debt (mrq) | 1.61B |
| Total debt/equity (mrq) | 95.36% |
| Current ratio (mrq) | 2.79 |
| Book value per share (mrq) | 20.69 |
Cash flow statement
| Operating cash flow (ttm) | 208.08M |
| Levered free cash flow (ttm) | 224.21M |
© 2023 Yahoo. All rights reserved.
